SequelSEC

Tectonic Therapeutic, Inc. TECX

Biological Products, (No Diagnostic Substances) · CIK 0001681087 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
Unavailable
Fiscal year ended 2026-06-30
Operating income
-$24.22M
Fiscal year ended 2026-06-30
Free cash flow
-$21.53M
Fiscal year ended 2026-06-30

Tectonic Therapeutic, Inc. (TECX) reported net income of -$22.28M for the fiscal year ended 2026-06-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from Tectonic Therapeutic, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Biological Products, (No Diagnostic Substances).

Income

Tectonic Therapeutic, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
RevenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Cost of revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Gross profitUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Operating income-$24.22MUnavailable-$21.52M-$21.89MUnavailableUnavailable-$13.99M-$19.64MUnavailableUnavailable
Net income-$22.28MUnavailable-$19.23M-$19.04MUnavailableUnavailable-$12.37M-$17.72MUnavailableUnavailable
Research & development$18.05MUnavailable$16.34M$16.93MUnavailableUnavailable$9.16M$14.32MUnavailableUnavailable
Weighted-average diluted sharesshares 18.96MUnavailableUnavailableshares 18.71MUnavailableUnavailableUnavailableshares 14.73MUnavailableUnavailable
Pretax income-$22.21MUnavailable-$18.97M-$19.04MUnavailableUnavailable-$12.37M-$17.72MUnavailableUnavailable
Income tax expense$77.00KUnavailable$254.00K$0UnavailableUnavailable$0$0UnavailableUnavailable
Diluted EPS$-1.18UnavailableUnavailable$-1.02UnavailableUnavailableUnavailable$-1.20UnavailableUnavailable
Selling, general & administrativeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable$0UnavailableUnavailable
General & administrative$6.17MUnavailable$5.18M$4.96MUnavailableUnavailable$4.84M$5.32MUnavailableUnavailable
Selling & marketingUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Balance

Tectonic Therapeutic, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Cash & equivalents$227.07MUnavailable$253.80M$268.44MUnavailableUnavailable$141.24M$159.10MUnavailableUnavailable
Total assets$237.03MUnavailable$261.04M$277.00MUnavailableUnavailable$152.90M$168.72MUnavailableUnavailable
Current assets$231.10MUnavailable$257.36M$273.24MUnavailableUnavailable$146.86M$162.60MUnavailableUnavailable
Total liabilities$13.19MUnavailable$9.71M$9.47MUnavailableUnavailable$12.13M$18.36MUnavailableUnavailable
Current liabilities$10.37MUnavailable$9.67M$9.37MUnavailableUnavailable$11.61M$17.32MUnavailableUnavailable
Total equity incl. NCI$223.85MUnavailable$251.33M$267.53MUnavailableUnavailable$140.78M$150.36MUnavailableUnavailable
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable$0$0UnavailableUnavailable
InventoryUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts receivableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
GoodwillUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debtUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts payable$1.68MUnavailable$1.09M$1.48MUnavailableUnavailable$976.00K$2.64MUnavailableUnavailable

Cash flow

Tectonic Therapeutic, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Operating cash flow-$21.45MUnavailable-$14.46M-$17.82MUnavailableUnavailable-$16.82M-$19.60MUnavailableUnavailable
Capital expenditures$79.00KUnavailable$0$181.00KUnavailableUnavailable$3.00K$153.00KUnavailableUnavailable
Investing cash flow-$59.00KUnavailable$0-$166.00KUnavailableUnavailable-$3.00K-$153.00KUnavailableUnavailable
Financing cash flow$11.68MUnavailable-$141.00K-$457.00KUnavailableUnavailable-$1.07M-$6.29MUnavailableUnavailable
Net change in cash-$9.83MUnavailable-$14.64M-$18.46MUnavailableUnavailable-$17.86M-$26.03MUnavailableUnavailable
Stock-based compensation$4.01MUnavailable$2.99M$2.82MUnavailableUnavailable$1.12M$1.65MUnavailableUnavailable
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Depreciation & amortization$285.00KUnavailable$333.00K$342.00KUnavailableUnavailable$508.00K$424.00KUnavailableUnavailable

Derived

Tectonic Therapeutic, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Free cash flow-$21.53MUnavailable-$14.46M-$18.00MUnavailableUnavailable-$16.82M-$19.76MUnavailableUnavailable
Gross marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Operating marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
FCF marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
SBC / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Current ratio22.29xUnavailable26.63x29.15xUnavailableUnavailable12.65x9.39xUnavailableUnavailable
Revenue YoY growthUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Net marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
R&D / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
CapEx / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debt / equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open TECX in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-06View SEC filing
10-Q · Filed 2026-05-07View SEC filing
10-K · Filed 2026-02-26View SEC filing
10-Q · Filed 2025-11-06View SEC filing
10-Q · Filed 2025-08-07View SEC filing
10-Q · Filed 2025-05-08View SEC filing

Companies in the same industry

ABOS ABPO ACOG ADAPY ADMA ADPT AGEN AGTX AIM ALEC ALGS ALLO

Reconciliation checks needing review

16 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.

gross profit bridgeinconsistent2026-03-31

Withheld: cost revenue, revenue could not be reconciled with the rest of this filer’s statement.

balance equationinconsistent2026-03-31

Withheld: assets, equity, liabilities could not be reconciled with the rest of this filer’s statement.

balance equationinconsistent2025-06-30

Withheld: assets, equity, liabilities could not be reconciled with the rest of this filer’s statement.

gross profit bridgeinconsistent2025-06-30

Withheld: cost revenue, revenue could not be reconciled with the rest of this filer’s statement.

gross profit bridgeinconsistent2025-03-31

Withheld: cost revenue, revenue could not be reconciled with the rest of this filer’s statement.

balance equationinconsistent2025-03-31

Withheld: assets, equity, liabilities could not be reconciled with the rest of this filer’s statement.

balance equationinconsistent2024-06-30

Withheld: assets, equity, liabilities could not be reconciled with the rest of this filer’s statement.

gross profit bridgeinconsistent2024-06-30

Withheld: cost revenue, revenue could not be reconciled with the rest of this filer’s statement.

gross profit bridgeinconsistent2024-03-31

Withheld: cost revenue, revenue could not be reconciled with the rest of this filer’s statement.

balance equationinconsistent2024-03-31

Withheld: assets, equity, liabilities could not be reconciled with the rest of this filer’s statement.

gross profit bridgeinconsistent2023-06-30

Withheld: cost revenue, revenue could not be reconciled with the rest of this filer’s statement.

balance equationinconsistent2023-06-30

Withheld: assets, equity, liabilities could not be reconciled with the rest of this filer’s statement.